BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2025-05

211 industry Phase 2/3 trial readout(s) and 35 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2025-04 | 2025-06 →

FDA decision events

DateEventStatusCompanyDrugSource
2025-05-05FDA AdComheldAdCom 2025-05-05: Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee
2025-05-08FDA approvalapprovedVERASTEM INC VSTMAVMAPKI FAKZYNJA CO-PACK (COPACKAGED)Approved 2025-05-08: AVMAPKI FAKZYNJA CO-PACK (COPACKAGED) (NDA219616 ORIG1)
2025-05-09FDA approvalapprovedOTSUKAREXULTIApproved 2025-05-09: REXULTI (NDA205422 SUPPL14)
2025-05-09FDA approvalapprovedGE HEALTHCAREOPTISONApproved 2025-05-09: OPTISON (NDA020899 SUPPL25)
2025-05-14FDA approvalapprovedMERCK SHARP DOHME MRKWELIREGApproved 2025-05-14: WELIREG (NDA215383 SUPPL12)
2025-05-14FDA approvalapprovedAMNEAL AMRXBREKIYA (AUTOINJECTOR)Approved 2025-05-14: BREKIYA (AUTOINJECTOR) (NDA215400 ORIG1)
2025-05-14FDA approvalapprovedGENENTECHKADCYLAApproved 2025-05-14: KADCYLA (BLA125427 SUPPL121)
2025-05-14FDA approvalapprovedABBVIE INC ABBVEMRELISApproved 2025-05-14: EMRELIS (BLA761384 ORIG1)
2025-05-15Complete response lettercomplete responseStealth BioTherapeutics Inc.elamipretide injectionCRL 2025-05-15: Stealth BioTherapeutics Inc. NDA 215244 (elamipretide injection)
2025-05-15FDA approvalapprovedINCYTE CORP INCYZYNYZApproved 2025-05-15: ZYNYZ (BLA761334 SUPPL4)
2025-05-20FDA AdComheldGenentech, Inc.AdCom 2025-05-20: Oncologic Drugs Advisory Committee - sBLA 761309/S-001
2025-05-20FDA approvalapprovedAMGEN INC AMGNAMJEVITAApproved 2025-05-20: AMJEVITA (BLA761024 SUPPL21)
2025-05-20FDA approvalapprovedBOEHRINGER INGELHEIMCYLTEZOApproved 2025-05-20: CYLTEZO (BLA761058 SUPPL31)
2025-05-21FDA approvalapprovedGENENTECH INCSUSVIMOApproved 2025-05-21: SUSVIMO (BLA761197 SUPPL7)
2025-05-22FDA AdComheldAdCom 2025-05-22: Vaccines and Related Biological Products Advisory Committee
2025-05-22FDA approvalapprovedONYX PHARMS AMGENKYPROLISApproved 2025-05-22: KYPROLIS (NDA202714 SUPPL36)
2025-05-22FDA approvalapprovedVERTEX PHARMS VERXKALYDECOApproved 2025-05-22: KALYDECO (NDA203188 SUPPL41)
2025-05-22FDA approvalapprovedAMGEN AMGNPROLIA; XGEVAApproved 2025-05-22: PROLIA; XGEVA (BLA125320 SUPPL219)
2025-05-22FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDAApproved 2025-05-22: KEYTRUDA (BLA125514 SUPPL182)
2025-05-22FDA approvalapprovedVERTEX PHARMS INC VERXKALYDECOApproved 2025-05-22: KALYDECO (NDA207925 SUPPL19)
2025-05-22FDA approvalapprovedABBVIE ENDOCRINE INC ABBVLUPRON DEPOT-PED KITApproved 2025-05-22: LUPRON DEPOT-PED KIT (NDA020263 SUPPL56)
2025-05-22FDA approvalapprovedGLAXOSMITHKLINE LLCNUCALAApproved 2025-05-22: NUCALA (BLA125526 SUPPL7)
2025-05-22FDA approvalapprovedARCUTIS ARQTZORYVEApproved 2025-05-22: ZORYVE (NDA217242 SUPPL5)
2025-05-22FDA approvalapprovedBIO-THERA SOLUTIONS LTDSTARJEMZAApproved 2025-05-22: STARJEMZA (BLA761419 ORIG1)
2025-05-23FDA approvalapprovedLIQUIDIA TECH LQDAYUTREPIAApproved 2025-05-23: YUTREPIA (NDA213005 ORIG1)
2025-05-23FDA approvalapprovedBRISTOL MYERS SQUIBB BMYYERVOYApproved 2025-05-23: YERVOY (BLA125377 SUPPL136)
2025-05-23FDA approvalapprovedBRISTOL MYERS SQUIBB BMYOPDIVOApproved 2025-05-23: OPDIVO (BLA125554 SUPPL133)
2025-05-28FDA approvalapprovedBOEHRINGER INGELHEIM PHARMACEUTICALS INCSPEVIGOApproved 2025-05-28: SPEVIGO (BLA761244 SUPPL4)
2025-05-28FDA approvalapprovedETON ETONKHINDIVIApproved 2025-05-28: KHINDIVI (NDA218980 ORIG1)
2025-05-28FDA approvalapprovedALCON LABS INC ALCTRYPTYRApproved 2025-05-28: TRYPTYR (NDA217370 ORIG1)
2025-05-29Complete response lettercomplete responseChemo Research, S.L.ethinyl estradiolCRL 2025-05-29: Chemo Research, S.L. NDA 219029 (dienogest and ethinyl estradiol tablets)
2025-05-30FDA approvalapprovedGENENTECH INCXOFLUZAApproved 2025-05-30: XOFLUZA (NDA210854 SUPPL23)
2025-05-30FDA approvalapprovedDR REDDYS LABS SAPHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDEApproved 2025-05-30: PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE (NDA216830 ORIG1)
2025-05-30FDA approvalapprovedPOLAREANXENOVIEWApproved 2025-05-30: XENOVIEW (NDA214375 SUPPL1)
2025-05-30FDA approvalapprovedGENENTECH INCXOFLUZAApproved 2025-05-30: XOFLUZA (NDA214410 SUPPL8)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2025-05 est.P1/P2InnoUp Farma S.L.NCT04163562 Oral Immunotherapy for Peanut Allergic PatientsPeanut Allergyrecruiting50
2025-05 est.P2Tessa TherapeuticsNCT04268706 Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)Hodgkin Lymphoma, Adult; Hodgkin Disease Recurrent; Hodgkin Disease Refractory; Hodgkin Disease, Pedactive not recruiting97
2025-05 est.P2Kyowa Kirin, Inc.NCT04745234 Mogamulizumab Q4week Dosing in Participants With R/R CTCLCutaneous T-Cell Lymphoma, Relapsed; Cutaneous T-Cell Lymphoma Refractoryunknown34
2025-05 est.P2Avobis Bio, LLCNCT04847739 Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)Perianal Fistula; Crohn's Diseaseunknown60
2025-05 est.P3Romark Laboratories L.C.NCT05157243 Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe IllnessCOVID-19withdrawn
2025-05 est.P3TYK Medicines, IncNCT05382728 Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)NSCLC; EGFR Activating Mutationrecruiting680
2025-05 est.P2Hepion Pharmaceuticals, Inc. HEPANCT05402371 A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver FibrosisNonalcoholic Steatohepatitis (NASH); Fibrosis, Liver; NAFLDunknown120
2025-05 est.P1/P2Shanghai Hengrui Pharmaceutical Co., Ltd.NCT05410730 A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBCHigh-risk NMIBCrecruiting150
2025-05 est.P3Blau Farmaceutica S.A.NCT05704894 Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in ChildrensAnemia; Neoplasms; Chemotherapeutic-Induced Anemiaunknown320
2025-05 est.P1/P2Shanghai Blueray Biopharma Co., Ltd.NCT05749549 Phase I/IIa Study of BR1733 in Subjects With Advanced CancersAdvanced Cancer; Follicular Lymphoma; Peripheral T Cell Lymphoma; Diffuse Large B Cell Lymphomaunknown191
2025-05 est.P1/P2RemeGen Co., Ltd.NCT05804526 A Study of RC88 Combined With Sintilimab for Advanced Solid TumoursAdvanced Solid Tumoursunknown82
2025-05 est.P2Mundipharma Research LimitedNCT05835479 Rezafungin for Treatment of Pneumocystis Pneumonia in HIV AdultsPneumocystis Pneumoniarecruiting50
2025-05 est.P2JemincareNCT05967520 JMKX000189 for Moderate to Severe Active Systemic Lupus ErythematosusLupus Erythematosus, Systemicunknown48
2025-05 est.P3Pharmbio Korea Co., Ltd.NCT06154187 Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With OsteoporosisOsteoporosisunknown60
2025-05 est.P1/P2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT06237400 A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.KRAS G12C Mutant Advanced Solid Tumorsunknown110
2025-05 est.P2ImmuneMed, Inc.NCT06306339 A Study to Assess the Efficacy and Safety of Burfiralimab (hzVSF-v13) and DMRD (Disease-modifying Antirheumatic Drug)Moderate to Severe Rheumatoid Arthritisunknown60
2025-05 est.P2Genrix (Shanghai) Biopharmaceutical Co., Ltd.NCT06315426 A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR).Allergic Rhinitisactive not recruiting240
2025-05 est.P1/P2Technophage, SANCT06370598 Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated PneumoniaPneumonia, Ventilator-Associatedunknown15
2025-05 est.P1/P2Jiangsu Topcel-KH Pharmaceutical Co., Ltd.NCT06438809 Umbilical-Cord-Derived Mesenchymal Stem Cells Injection for Chronic Radiation ProctitisChronic Radiation Proctitisunknown24
2025-05 est.P1/P2Shanghai Mabgeek Biotech.Co.LtdNCT06765005 IB/IIa Study of MG-K10 in Adolescent Moderately Severe PatientsAtopic Dermatitisrecruiting24
2025-05 est.P3PharmaResearch Co.,LtdNCT06779071 Pivotal Clinical Trial to Evaluate the Efficacy and Safety After NPNP-001 Application in Patients with Knee Osteoarthritis.Knee Osteoarthritisenrolling by invitation260
2025-05-01P3Curonix LLCNCT02725554 Study of Wireless Nerve Stimulation in the Treatment of Chronic MigraineMigrainewithdrawn
2025-05-01P1/P2Regeneron Pharmaceuticals REGNNCT04083534 First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)Relapsed Multiple Myeloma; Refractory Multiple Myelomacompleted43
2025-05-01 est.P2/P3Advicenne PharmaNCT04147871 Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest ChildrenCystinuriawithdrawn
2025-05-01 est.P3RDC Clinical Pty LtdNCT06006416 Effect of Fenugreek Fibre on Gut MicrobiomeGut Microbiomewithdrawn
2025-05-01 est.P3Changchun GeneScience Pharmaceutical Co., Ltd.NCT06007417 A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone DeficiencyGHDunknown162
2025-05-01 est.P3Changchun GeneScience Pharmaceutical Co., Ltd.NCT06024967 A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone DeficiencyGHDunknown180
2025-05-01 est.P2/P3LumiThera, Inc.NCT06229665 Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)Dry Age-related Macular Degenerationunknown75
2025-05-01P3Viridian Therapeutics, Inc. VRDNNCT06384547 A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)Thyroid Eye Diseasecompleted231
2025-05-01P2Sutro Biopharma, Inc. STRONCT06555263 Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung CancerLung Cancer; Lung Cancer Metastatic; Lung Cancer, Nonsmall Cell; Lung Cancer Non-Small Cell Stage IIwithdrawn
2025-05-02P1/P2JCR Pharmaceuticals Co., Ltd.NCT04453085 An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)Mucopolysaccharidosis Icompleted14
2025-05-02P3AbbVie ABBVNCT05216263 Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic MigrChronic Migrainecompleted75
2025-05-02P2Hoffmann-La RocheNCT05548556 A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular DystrophyFacioscapulohumeral Muscular Dystrophy (FSHD)completed51
2025-05-02P1/P2Sanofi Pasteur, a Sanofi Company SNYNCT05639894 Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and OlderRespiratory Syncytial Virus Immunizationcompleted865
2025-05-02P3Jiangsu HengRui Medicine Co., Ltd.NCT05994378 To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female SubjectsInfertile Female Subjects Undergoing Controlled Ovarian Hyperstimulation to Suppress Premature LH Sucompleted317
2025-05-02P2Boehringer IngelheimNCT06558344 A Study to Test Different Doses of BI 1569912 in People With DepressionDepressive Disorder, Majorcompleted225
2025-05-03P3Colgate Palmolive CLNCT06957249 Clinical Study to Evaluate the Tooth Whitening EfficacyWhiteningcompleted80
2025-05-05P3BiotestNCT05531149 Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 PneumoniaRespiratory Infection; Pneumonia; Community-acquired Pneumonia; Acute Respiratory Distress Syndrome;terminated107
2025-05-05P2Neuvosyn Laboratories, LLCNCT05712421 A Study Evaluation the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Patients With Primary HypothyroidismHypothyroidismcompleted303
2025-05-05P3LEO PharmaNCT05958407 A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic TheraAtopic Dermatitis; Atopic Hand Eczemacompleted235
2025-05-05P3Takeda TAKNCT06060067 A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in IndiaHealthy Volunteerscompleted480
2025-05-06 est.P2AstraZeneca AZNNCT03944772 Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)Non-Small Cell Lung Canceractive not recruiting247
2025-05-06P3LG ChemNCT05586971 Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout PatientsGout; Hyperuricemia; Gout Flare; Tophicompleted2202
2025-05-06P3GuerbetNCT06010173 Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and ChildrenLesion in Body Region; CNS Lesioncompleted240
2025-05-06P2Nektar Therapeutics NKTRNCT06136741 A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic DermatitisModerate to Severe Atopic Dermatitisactive not recruiting396
2025-05-06P2Recursion Pharmaceuticals Inc. RXRXNCT06536465 The Clostridioides Difficile Trial of REC-3964Recurrent Clostridioides Difficile Infectionterminated3
2025-05-06P2Shanghai JunTop Biosciences Co., LTDNCT06861101 Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in AdultsSeasonal Allergic Rhinitiscompleted370
2025-05-07P3AstraZeneca AZNNCT04191304 A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)Hypereosinophilic Syndromeactive not recruiting134
2025-05-07P3Takeda TAKNCT04701411 A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn's DiseaseCrohn's Disease; Complex Perianal Fistulaterminated7
2025-05-07 est.P3Xuanzhu Biopharmaceutical Co., Ltd.NCT05204628 A Study to Evaluate and Compare the Efficacy and Safety of XZP-3621 Versus CrizotinibNon-small Cell Lung Cancerunknown238
2025-05-07P3Novartis Pharmaceuticals NVSNCT05350072 Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's SyndromeSjogren Syndromecompleted275
2025-05-07 est.P2Xuanzhu Biopharmaceutical Co., Ltd.NCT05482087 A Study of XZP-3621 in Chinese Patients With ALK Positive NSCLCALK-positive NSCLCunknown190
2025-05-07P3Hoffmann-La RocheNCT05642325 Vamikibart in Participants With Uveitic Macular EdemaUveitic Macular Edemacompleted256
2025-05-07P3Apnimed APMDNCT05811247 Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)OSAcompleted660
2025-05-07P3Alexion Pharmaceuticals, Inc.NCT05876351 Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in ChinaAtypical Hemolytic Uremiccompleted25
2025-05-07P2Merz Therapeutics GmbHNCT06091020 A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic NModerate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or completed123
2025-05-07P2Beijing QL Biopharmaceutical Co.,LtdNCT07020884 A Study of ZT002 Injection With Subjects With Overweight or ObesityOverweight or Obesitycompleted303
2025-05-08P2Sermonix Pharmaceuticals Inc.NCT03781063 Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationLocally Advanced or Metastatic Breast Cancercompleted100
2025-05-08P3Zogenix, Inc.NCT03936777 A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including DDravet Syndrome; Lennox Gastaut Syndrome; Epileptic Encephalopathycompleted412
2025-05-08P3Gamida Cell ltdNCT04260698 Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological MalignanciesHematological Malignanciescompleted36
2025-05-08P3Janssen Research & Development, LLCNCT04630028 A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)Colitis, Ulcerativecompleted112
2025-05-08P2/P3Cellphire Therapeutics, Inc.NCT04709705 DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS)Cardiac Surgerycompleted161
2025-05-08P2Mural Oncology, IncNCT04830124 Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6Cutaneous Melanoma; Mucosal Melanomaterminated173
2025-05-08P3Merck Sharp & Dohme LLC MRKNCT04949256 Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-0Metastatic Esophageal Squamous Cell Carcinomaterminated863
2025-05-08P3AllerganNCT05452070 A Study to Assess Adverse Events and Change in Disease Activity of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft Tissue Augmentation in Adult ParticipantMid Face Volume Deficitcompleted171
2025-05-08P2Amgen AMGNNCT05591222 Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus ErythematosusDiscoid Lupus Erythematosusterminated72
2025-05-08P3Hoffmann-La RocheNCT05904886 A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular CarciHepatocellular Carcinomaactive not recruiting687
2025-05-08P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06198751 A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast CancerBreast Canceractive not recruiting104
2025-05-08P3Novo Nordisk A/S NVONCT06340854 A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily InDiabetes, Type 2completed412
2025-05-08P2Gilead Sciences GILDNCT06585150 Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) InfectionRSV Infectionterminated150
2025-05-08P2Evommune, Inc. EVMNNCT06603220 A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible UrticariaChronic Inducible Urticariacompleted30
2025-05-08P3Hoffmann-La RocheNCT06774859 Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza SymptomsInfluenzacompleted100
2025-05-09P1/P2Inovio Pharmaceuticals INONCT03502785 INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial CarcinomaUrothelial Carcinomacompleted35
2025-05-09P1/P2Jacobio Pharmaceuticals Co., Ltd.NCT05174585 JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid TumorsSolid Tumorcompleted21
2025-05-09 est.P2Ashvattha Therapeutics, Inc.NCT05387837 Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DMENeovascular Age-related Macular Degeneration; Diabetic Macular Edemaactive not recruiting50
2025-05-09P2PharmaEssentiaNCT05482971 A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ETEssential Thrombocythemiaactive not recruiting91
2025-05-09P2Telix Pharmaceuticals (Innovations) Pty Ltd TLXNCT05563272 89Zr-girentuximab for PET Imaging of CAIX Positive Solid TumorsCervical Cancer; Colorectal Cancer; Esophageal Cancer; Gastric Cancer; Glioblastoma Multiforme; Cholterminated11
2025-05-09P2Novatek PharmaceuticalsNCT05785390 Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.COVID-19terminated170
2025-05-09P2AstraZeneca AZNNCT06350123 Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney DiseaseChronic Kidney Diseasecompleted324
2025-05-09P2/P3Cessatech A/SNCT06364072 Safety, Tolerability, Analgesic Effect, and Feasibility of Intranasal CT001 in Pediatric PatientsPaincompleted155
2025-05-09P3MAXVAX Biotechnology Limited Liability CompanyNCT06654700 Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).Herpes Zostercompleted1200
2025-05-10P3Alexion Pharmaceuticals, Inc.NCT04504825 A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)AL Amyloidosisactive not recruiting125
2025-05-10 est.P2Gannex Pharma Co., Ltd.NCT05462353 Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASHNon-alcoholic Fatty Liver Disease; Non-alcoholic Steatohepatitisunknown183
2025-05-10 est.P2Kayuraeffect, LLPNCT06473974 Open-label, Single-arm, Proof of Concept Study in Subjects with Mild-to-moderate Facial HyperpigmentationFacial Hyperpigmentationwithdrawn
2025-05-10P3Regeneron Pharmaceuticals REGNNCT06602726 A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat AllergyAllergic Conjunctivitiscompleted64
2025-05-12P2Inmune Bio, Inc. INMBNCT05318976 A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of InflammationAlzheimer Disease; Dementia; Brain Diseases; Central Nervous System Diseases; Nervous System Diseasecompleted207
2025-05-12P2ABO Holdings, Inc.NCT05662852 Safety and Immunogenicity Study of Tdap Vaccinations for Plasma DonorsTetanus, Diphtheria and Acellular Pertussis Vaccinationcompleted107
2025-05-12P3Haisco Pharmaceutical Group Co., Ltd.NCT06643078 A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients With COPDChronic Obstructive Pulmonary Disease (COPD)completed487
2025-05-12P2Shaanxi Micot Pharmaceutical Technology Co., Ltd.NCT06747247 A Clinical Study Evaluating the Safety, Tolerability, and Efficacy of MT1013 in Hemodialysis Subjects With Secondary HyperparathyroidismSecondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysiscompleted98
2025-05-13P3DBV Technologies DBVTNCT03859700 Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young ChildrenPeanut Allergycompleted304
2025-05-13P3Novartis Pharmaceuticals NVSNCT05349214 Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's SyndromeSjogren Syndromeactive not recruiting506
2025-05-13P3Beijing Mabworks Biotech Co., Ltd.NCT05862233 A Phase Ⅲ Clinical Study of MIL62 in Primary Membranous NephropathyPrimary Membranous Nephropathyunknown150
2025-05-13P3Formycon AGNCT06643117 Similar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Patients With Non-squamous Non-small Cell Lung CanNon Small Cell Lung Cancer; Non-Squamous Non-Small Cell Lung Cancerterminated25
2025-05-13P3Jiangsu HengRui Medicine Co., Ltd.NCT06871761 A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 DiabetesAdult Patients With Type 2 Diabetescompleted393
2025-05-13P3Colgate Palmolive CLNCT06960148 Dentinal Hypersensitivity Reduction Efficacy StudySensitivity, Toothcompleted95
2025-05-14P1/P2Oncoinvent Solutions ASNCT03732781 Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPECPeritoneal Carcinoma; Colorectal Carcinomacompleted47
2025-05-14P2PDS Biotechnology Corp. PDSBNCT04260126 Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCCMetastatic Head and Neck Cancer; Recurrent Head and Neck Cancer; HPV Positive Oropharyngeal Squamouscompleted95
2025-05-14P2Omeicos Therapeutics GmbHNCT05972954 OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION)Primary Mitochondrial Diseasecompleted28
2025-05-14 est.P2Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.NCT05997602 To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCHLangerhans Cell Histiocytosis; LCHrecruiting56
2025-05-14P3CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT06161844 Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes MellitusType 2 Diabetes Mellituscompleted506
2025-05-14P2/P3Beijing Protgen Biotechnology Development Co., Ltd.NCT06553456 Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With AscitesCirrhotic Ascitescompleted390
2025-05-15P3CelgeneNCT04140305 Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)Multiple Sclerosisterminated188
2025-05-15 est.P3Jiangsu HengRui Medicine Co., Ltd.NCT04691063 The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.Small-cell Lung Cancerunknown486
2025-05-15P2SymBio PharmaceuticalsNCT04706923 A Phase 2a Study of IV BCV in Subjects With Adenovirus InfectionAdenovirus Infections; Cytomegalovirus Infectioncompleted53
2025-05-15P3Vera Therapeutics, Inc. VERANCT04716231 Atacicept in Subjects With IgA NephropathyIgA Nephropathy; Berger Diseaseactive not recruiting428
2025-05-15P2Janssen Research & Development, LLCNCT05242484 A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisColitis, Ulcerativeactive not recruiting577
2025-05-15P3Grünenthal GmbHNCT05377489 Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the KneeOsteoarthritiscompleted714
2025-05-15P3Novartis Pharmaceuticals NVSNCT05456191 A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed PhilaPhiladelphia Chromosome-Positive Chronic Myeloid Leukemiaactive not recruiting568
2025-05-15P2Compass Therapeutics COMPNCT05513742 A Study of CTX-009 in Adult Patients With Metastatic Colorectal CancerMetastatic Colorectal Cancer; Colon Cancer; Rectal Cancercompleted49
2025-05-15P3Conceptra Biosciences, LLCNCT06121063 CCT-102 or Expectant Management in Delayed Pregnancy LossEarly Pregnancy Loss, Delayed Pregnancy Losscompleted183
2025-05-15P3Alexion Pharmaceuticals, Inc.NCT06578949 Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Ravulizumab in Chinese Adults Participants With Paroxysmal Nocturnal Hemoglobinuria Paroxysmal Nocturnal Hemoglobinuria; PNHcompleted18
2025-05-15 est.P2Healthgen Biotechnology Corp.NCT06722664 Efficacy and Safety of OsrhCT and Dimethicone Emulsion Before Upper Endoscopy on Visualization of the Gastric Mucosa.Gastric Mucosal Lesionactive not recruiting336
2025-05-16P3Alfasigma S.p.A.NCT03025308 Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid ArthritisRheumatoid Arthritiscompleted2731
2025-05-16P3Hutchmed HCMNCT05029635 Phase III Study on HMPL-523 for Treatment of ITPPrimary Immune Thrombocytopenia (ITP)completed272
2025-05-16P2Otsuka Pharmaceutical Development & Commercialization, Inc.NCT05536414 Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive DisorderMajor Depressive Disordercompleted337
2025-05-16P2Beijing Suncadia Pharmaceuticals Co., LtdNCT06471218 Efficacy and Safety of SHR-1918 in Patients With HyperlipidemiaHyperlipidemiacompleted44
2025-05-17P3Guangdong Longchuangji Pharmaceutical Co., Ltd.NCT07418957 Efficacy and Safety of Vaginal Lactobacillus Dual Probiotic Capsules in Bacterial VaginosisBacterial Vaginosis (BV)completed402
2025-05-19P3GlaxoSmithKlineNCT05243680 An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)Asthmacompleted641
2025-05-19P1/P2GlaxoSmithKlineNCT05330455 Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B InfectionHepatitis Bterminated74
2025-05-19P3Ascletis Pharmaceuticals Co., Ltd.NCT06192264 A Study to Evaluate the Safety and Efficacy of ASC40 (Denifanstat) Tablets in the Treatment of Patients With Moderate to Severe Acne VulgarisAcnecompleted480
2025-05-19P3Hyundai PharmNCT06646354 To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary HypercholesterolemiaHypertension; Primary Hypercholesterolaemiaenrolling by invitation125
2025-05-20P3Il-Yang Pharm. Co., Ltd.NCT04381689 Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy InfantsHealthycompleted260
2025-05-20P2Prokidney PROKNCT05018416 Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)Chronic Kidney Diseases; Type 1 Diabetes Mellitus; Type 2 Diabetes Mellituscompleted53
2025-05-20P2/P3Incannex Healthcare Ltd IXHLNCT06146101 RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSAObstructive Sleep Apneacompleted121
2025-05-20P2Biomea Fusion Inc. BMEANCT06152042 Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes MellitusType 1 Diabetes Mellituscompleted37
2025-05-20P2Neuraly, Inc.NCT06410924 A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASHNAFLD; NASHcompleted67
2025-05-20P3Dexa Medica GroupNCT06558071 Supplementation of Galatonol 300 mg / Striatin 30 mg in Postpartum Lactating MothersLactation Inducedcompleted160
2025-05-20P1/P2AeroRx Therapeutics Inc.NCT06841640 Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPDCOPDcompleted24
2025-05-20P1/P2Genrix (Shanghai) Biopharmaceutical Co., Ltd.NCT07102706 Phase I Trial of GR1803 Injection in Patients With RRMMMultiple Myeloma (MM)completed76
2025-05-21P2Merck Sharp & Dohme LLC MRKNCT04895722 Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or MismatcColorectal Cancercompleted302
2025-05-21P2Novartis Pharmaceuticals NVSNCT05172596 PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple MyelomaMultiple Myelomaterminated146
2025-05-21P2River 3 Renal Corp.NCT05267262 Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental GlomerulosclerosisAlport Syndrome; Focal Segmental Glomerulosclerosiscompleted43
2025-05-21P3AstraZeneca AZNNCT06034743 A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants WiUncontrolled Hypertension; Resistant Hypertensioncompleted796
2025-05-21P3Incyte Corporation INCYNCT06238817 A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic DermatitisAtopic Dermatitiscompleted241
2025-05-21P2Island PharmaceuticalsNCT06528457 Study to Examine the Effects of Oral FenretinideDenguecompleted15
2025-05-22P2Bristol-Myers Squibb BMYNCT04702880 A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung CancerExtensive-stage Small Cell Lung Cancercompleted135
2025-05-22P2Cogent Biosciences, Inc. COGTNCT05186753 (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic MastocytosisSSM; Mastocytosis, Indolent; Mastocytosis, Systemic; Mastocytosis; ISM; BMM; Smoldering Systemic Masactive not recruiting237
2025-05-22P2AstraZeneca AZNNCT05516498 Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)Liver Cirrhosisterminated205
2025-05-22P1/P2GlaxoSmithKlineNCT05630859 Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of AgeSexually Transmitted Diseasescompleted1009
2025-05-22P2NexEos Diagnostics, Inc.NCT05757856 A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic EsophagitisEosinophilic Esophagitiscompleted34
2025-05-22P3Kowa Research Institute, Inc.NCT05795699 A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)Fuchs Endothelial Corneal Dystrophycompleted107
2025-05-22P2Reunion Neuroscience IncNCT06342310 RE104 Safety and Efficacy Study in Postpartum DepressionPostpartum Depressioncompleted84
2025-05-23 est.P1/P2Editas Medicine, Inc. EDITNCT03872479 Single Ascending Dose Study in Participants With LCA10Leber Congenital Amaurosis 10; Inherited Retinal Dystrophies; Eye Diseases, Hereditary; Retinal Diseunknown34
2025-05-23P2Janssen Research & Development, LLCNCT05242471 A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's DiseaseCrohn's Diseaseactive not recruiting703
2025-05-23P2Lumosa Therapeutics Co., Ltd.NCT05403866 A Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS SubjectsAcute Ischemic Strokecompleted89
2025-05-23 est.P1/P2Imcyse SANCT05417269 IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS StudyMultiple Sclerosis, Relapsing-Remittingunknown150
2025-05-23P1/P2BeiGeneNCT05609370 A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus BevacizumaUnresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Canceractive not recruiting113
2025-05-23P2Soligenix SNGXNCT06386744 Dusquetide for the Treatment of Behcet's DiseaseBehçet Diseasecompleted8
2025-05-23P3RDC Clinical Pty LtdNCT06436781 Effect of Maolactin™ FMR on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy PopulationPost Exercise Inflammation; Exercise Recovery; Muscle Fatigue; Muscle Paincompleted33
2025-05-23P2MBX Biosciences MBXNCT06465108 Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With HypoparathyroidismHypoparathyroidismcompleted64
2025-05-23P2Jiangsu HengRui Medicine Co., Ltd.NCT06516926 SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid TumorsHER2-expressing or -Mutated Unresectable or Metastatic Solid Tumorsterminated11
2025-05-25 est.P3Beijing Zhifei Lvzhu Biopharmaceutical Co., LtdNCT06344065 Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old InfantsHealthy Volunteersrecruiting1584
2025-05-25P2Otsuka Pharmaceutical Development & Commercialization, Inc.NCT06795399 A Proof-of-concept Trial for OPC 131461 in Patients Hospitalized for Worsening Heart FailureHeart Failurewithdrawn
2025-05-26P3SK Life Science, Inc.NCT03678753 Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC SeizuresPrimary Generalized Epilepsycompleted169
2025-05-26P3CelgeneNCT04717414 An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Myeloproliferative Disorders; Myelofibrosis; Primary Myelofibrosis; Post-Polycythemia Vera Myelofibractive not recruiting313
2025-05-26P2Santen Inc.NCT05376176 A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs EndotheliaFuchs Endothelial Corneal Dystrophycompleted86
2025-05-26P1/P2ACELYRIN Inc.NCT05683496 Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED)Thyroid Eye Diseasecompleted31
2025-05-26P2Ausper Biopharma Co., Ltd.NCT06550128 Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).Hepatitis B, Chroniccompleted86
2025-05-26P2Prime Gene Therapeutics Co., Ltd.NCT06837233 A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic RhinitisSeasonal Allergic Rhinitiscompleted179
2025-05-27P2Clene Nanomedicine CLNNNCT03993171 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis.Multiple Sclerosiscompleted33
2025-05-27P3Hoffmann-La RocheNCT04513925 A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLCNon-small Cell Lung Cancer (NSCLC)completed829
2025-05-27P2GlaxoSmithKlineNCT05382312 Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of CarTuberculosiscompleted127
2025-05-27P3Alexion Pharmaceuticals, Inc.NCT05556096 Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia GravisGeneralized Myasthenia Gravisactive not recruiting260
2025-05-27P1/P2BeiGeneNCT05661955 A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With SeleUrothelial Carcinoma; Renal Cell Carcinoma; Melanoma; Non-mucosal Melanomaactive not recruiting113
2025-05-27P3Novo Nordisk A/S NVONCT06269107 A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People WiType 2 Diabetescompleted485
2025-05-27P2Vertex Pharmaceuticals Incorporated VERXNCT06619847 A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a BunionectomyAcute Paincompleted367
2025-05-27P3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06631170 Efficacy and Safety of Roflumilast Cream in Subjects With Atopic DermatitisAtopic Dermatitis (AD)completed354
2025-05-27P3Daewon Pharmaceutical Co., Ltd.NCT07093697 A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212Acute Bronchitiscompleted273
2025-05-28P1/P2Intima Bioscience, Inc.NCT04426669 A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH IGastrointestinal Epithelial Cancer; Gastrointestinal Neoplasms; Cancer of Gastrointestinal Tract; Cacompleted23
2025-05-28P1/P2Vor Biopharma VORNCT04849910 Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDLeukemia, Myeloid, Acute; Myelodysplastic Syndromesterminated67
2025-05-28P2Amgen AMGNNCT04933695 A Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation in Need of First-line TreatmentNon-small Cell Lung Cancerterminated42
2025-05-28P2Organon and Co OGNNCT05560646 A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe EndometriEndometriosiscompleted354
2025-05-28P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05563480 TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal CarcinomaNasopharyngeal Carcinomacompleted47
2025-05-28P3COMPASS Pathways CMPSNCT05624268 Efficacy, Safety, and Tolerability of COMP360 in Participants With TRDTreatment Resistant Depressioncompleted258
2025-05-28P3Laboratoire français de Fractionnement et de BiotechnologiesNCT05695391 Safety and Efficacy of FVIIa to Prevent Excessive Bleeding in Hemophilia Patients With Inhibitors Undergoing Major SurgeryHemophiliaterminated2
2025-05-28P1/P2Vor Biopharma VORNCT05984199 Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell TransplantLeukemia, Myeloid, Acuteterminated38
2025-05-28P1/P2BioNTech SE BNTXNCT06069544 A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against MalariaMalariacompleted163
2025-05-28P3Novartis Pharmaceuticals NVSNCT06236061 Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 MonotherapyHypertensioncompleted718
2025-05-28P3Jiangsu HengRui Medicine Co., Ltd.NCT06649773 The Experiment of Noiiglutide Injection in Type 2 Diabetes PatientsType 2 Diabetescompleted137
2025-05-28P2PepGen Inc PEPGNCT06833931 A Study of PGN-EDO51 or Placebo in People With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping TreatmentDuchenne Muscular Dystrophy (DMD)withdrawn
2025-05-29P2EIP Pharma IncNCT05869669 RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy BodiesDementia With Lewy Bodiescompleted159
2025-05-29P2Owlstone LtdNCT06193239 Diagnostic Accuracy Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution Phase 2)Lung Cancercompleted187
2025-05-29P3AO GENERIUMNCT06497491 An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still&#39;s DiseaseStill's Disease Adult Onsetcompleted118
2025-05-30P3Takeda TAKNCT04738942 A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's DiseaseUlcerative Colitis; Crohn's Diseaseactive not recruiting56
2025-05-30P3BeiGeneNCT04746924 A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung CancerNon-small Cell Lung Cancer; NSCLCterminated669
2025-05-30P2BayerNCT05059236 A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate CanMetastatic Hormone-sensitive Prostate Cancercompleted223
2025-05-30P3IO BiotechNCT05155254 IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)Metastatic Melanoma; Unresectable Melanomaactive not recruiting407
2025-05-30P2Fusion Pharmaceuticals Inc. HTOONCT05219500 Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST).Metastatic Castration Resistant Prostate Canceractive not recruiting115
2025-05-30P3Janssen Research & Development, LLCNCT05272150 Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp PsoriasisPlaque Psoriasis; Scalp Psoriasiscompleted211
2025-05-30P1/P2EnteromeNCT05589597 EO4010 in Previously Treated Metastatic Colorectal CarcinomaColorectal Cancer Metastaticterminated25
2025-05-30P1/P2Juventas Cell Therapy Ltd.NCT05667506 A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)B-cell Acute Lymphoblastic Leukemiarecruiting47
2025-05-30P2AbbVie ABBVNCT05785715 Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative ColitisUlcerative Colitisterminated81
2025-05-30P1/P2ModernaTX, Inc.NCT05975099 A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of AgeLyme Diseasecompleted807
2025-05-30P3Pfizer PFENCT05989048 A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian AdultsMigrainecompleted1414
2025-05-30P2BeiGeneNCT06010303 A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal SquamEsophageal Cancer; Esophageal Squamous Cell Carcinoma; Esophageal Squamous Cell Carcinoma by AJCC V8completed118
2025-05-30P2Eli Lilly and Company LLYNCT06230523 A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or OverweightObesity; Overweightcompleted263
2025-05-30 est.P1/P2GeneMedicine Co., Ltd.NCT06265025 GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsHead and Neck Cancer; Malignant Melanoma; Colorectal Cancer; Renal Cell Carcinoma; Cervical Cancer; recruiting125
2025-05-30P2/P3Bio-Thera SolutionsNCT06321068 BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial CancerEndometrial Cancerterminated5
2025-05-30 est.P1/P2Canwell Biotech LimitedNCT06410703 CAN1012 Combined With PD-1 in Patients With Solid TumorsAdvanced Solid Tumorunknown71
2025-05-30P2Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT06481085 To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusType 2 Diabetescompleted324
2025-05-30P3Addpharma Inc.NCT06747936 A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282Primary Hypercholesterolemiacompleted129
2025-05-31 est.P3Jina Pharmaceuticals Inc.NCT03671044 A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer PatientsTriple Negative Breast Cancerrecruiting657
2025-05-31 est.P3Liquidia Technologies, Inc. LQDANCT03992755 Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of TreprostinilPrimary Pulmonary Hypertensionactive not recruiting92
2025-05-31P2Beijing Biostar Pharmaceuticals Co., Ltd.NCT04911907 Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid TumorsSolid Tumorcompleted126
2025-05-31 est.P3Hutchison Medipharma LimitedNCT05015621 A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine CarcinomaAdvanced Neuroendocrine Carcinomaunknown194
2025-05-31P2Cardurion Pharmaceuticals, Inc.NCT06005428 Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)CPVT1; Heart Defects, Congenital; Heart Diseases; Ventricular Tachycardiaterminated7
2025-05-31P3Ferring PharmaceuticalsNCT06173869 A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU Infertility, Femalecompleted301
2025-05-31 est.P2Changchun BCHT Biotechnology Co.NCT06548139 Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical TrialsRabies Virus Infectionunknown120
2025-05-31 est.P3Macleods Pharmaceuticals LtdNCT06618105 Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of MaMild Asthmaunknown144
2025-05-31 est.P2/P3Shanghai Mabgeek Biotech.Co.LtdNCT06846385 Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic RhinitisSeasonal Allergic Rhinitisrecruiting160
2025-05-31P1/P2AO GENERIUMNCT07155499 A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V Rhinitis, Allergic, Seasonalcompleted150

← 2025-04 | 2025-06 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.